Related Experiment Video
Updated: Feb 8, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Randomized Phase II Study Comparing Mannitol with Furosemide for the Prevention of Renal Toxicity Induced by
Go Makimoto1, Eiki Ichihara, Katsuyuki Hotta
1Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Abstract:
Although cisplatin-based chemotherapy shows a survival advantage compared to carboplatin for treating advanced non-small cell lung cancer, high-volume hydration and a long infusion time are necessary to avoid nephrotoxicity, and cisplatin-based chemotherapy has been difficult to administer in outpatient settings. A low-volume hydration method using mannitol or furosemide as forced diuresis was recently introduced, but there are no clear conclusions regarding which agent should be used. We describe our ongoing randomized phase II trial (the OLCSG1406 Study) evaluating the efficacy of forced diuresis. This study will clarify whether mannitol or furosemide is more suitable in cisplatin-based chemotherapy with low-volume hydration.
Related Concept Videos
Cancer Prevention
Some...
Power System Three-Phase Short Circuits
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Serum Studies: Renal Function Tests
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Acute Kidney Injury IV: Diagnostic Studies and Prevention

